TLX Telix Pharmaceuticals Ltd
- 15.240
- +0.440+2.97%
Telix Pharmaceuticals Ltd News
Telix Pharmaceuticals Completes Acquisition of QSAM Biosciences and Drug Samarium-153-DOTMP
Telix Pharmaceuticals (ASX:TLX) finalized the acquisition of QSAM Biosciences and its lead investigational drug Samarium-153-DOTMP, according to a Friday filing with the Australian Securities Exchange
Bell Potter Downgrades Telix Pharmaceuticals Ltd. (TLPPF) to a Hold
Telix Pharmaceuticals Cut to Hold From Buy by Bell Potter >TLX.AU
Telix Pharmaceuticals Cut to Hold From Buy by Bell Potter >TLX.AU
Bell Potter Downgrades Telix Pharmaceuticals to Hold From Buy, Price Target Is AU$14.50
Telix Pharmaceuticals (ASX:TLX) has an average rating of buy and price targets ranging from AU$13.52 to AU$19.30, according to analysts polled by CapitalIQ. Price (AUD): $15.28, Change: $-0.23, Percen
AU Evening Wrap: Australia Shares End Flat Amid Interest-Rate Cut Uncertainty
The financial and property trust sectors led gains, both rising 0.4%, but industrials and utilities dragged, with each sector falling 0.6%.
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Telix Pharmaceuticals Ltd. (OtherTLPPF) and Intuitive Surgical (ISRG)
Jarden Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)
AU Evening Wrap: Australia Shares Rise 0.5% Amid Large-Cap Gains
The benchmark index shrugged off a soft lead by U.S. equities and was already higher when it jumped around the release of jobs data showing a continued gradual loosening of the country's employment market.
UBS Keeps Their Buy Rating on Telix Pharmaceuticals Ltd. (TLPPF)
Market Mover | TLX shares up 9%, released strong quarterly update
April 18, 2024 - Telix Pharmaceuticals Ltd(TLX.AU) shares jumped by 9.73% to reach A$13.760 on Thursday.
Why Is the Telix Share Price Jumping 15% to a Record High?
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is taking off on Thursday morning.
Jarden Adjusts Telix Pharmaceuticals Price Target to AU$13.52 From AU$13.27, Keeps at Buy
Telix Pharmaceuticals (ASX:TLX) has an average rating of buy and price targets ranging from AU$13.52 to AU$19.30, according to analysts polled by CapitalIQ.
Telix Pharmaceuticals Price Target Raised 2% to A$15.30/Share by Jefferies
Telix Pharmaceuticals Price Target Raised 2% to A$15.30/Share by Jefferies
Press Release: Q1 2024 Revenue and Business Update
Q1 2024 Revenue and Business Update MELBOURNE, Australia, April 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and o
QSAM Biosciences Announces 1-for-1,000 to 1-for-2,000 Reverse Stock Split Ahead of Merger With Telix >QSAM
QSAM Biosciences Announces 1-for-1,000 to 1-for-2,000 Reverse Stock Split Ahead of Merger With Telix >QSAM
Why Decmil, SCEE, Spartan Resources, and Telix Shares Are Pushing Higher
The S&P/ASX 200 Index (ASX: XJO) is having a day to forget on Tuesday. In afternoon trade, the benchmark index is down a very disappointing 2.1% to 7,586.6 points.
Telix Pharmaceuticals Secures US FDA Fast-Track Designation for Brain Cancer Imaging Product
Telix Pharmaceuticals (ASX:TLX) secured a fast-track designation from the US Food and Drug Administration for the brain cancer imaging product TLX101-CDx, according to a Tuesday filing with the Austra
'Critical Unmet Need': Why Everyone Is Talking About This ASX 200 Healthcare Stock
Telix Pharmaceuticals Ltd (ASX: TLX) shares are rising on Tuesday.
3 ASX 200 Healthcare Stocks That Could Deliver Big Returns for Investors
There could be some big returns on offer in the healthcare sector for Australian investors according to analysts.
Telix Pharmaceuticals Completes Acquisition of Canadian Firm ARTMS
Telix Pharmaceuticals (ASX:TLX) completed its acquisition of Canadian radioisotope production technology firm ARTMS, according to a Thursday filing with the Australian bourse. Telix Pharmaceuticals ma
Analysis
Price Target
No Data
